Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,988,427
+$560,567 QoQ
Shares Held
173,350
+11.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#390
of 2,516 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $440,141,055 across 10 Drug Manufacturers - General names. BMY ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
511,025 | $129,785,019 | |
| 2 | LLY |
ELI LILLY & Co
|
93,080 | $111,642,953 | |
| 3 | MRK |
Merck & Co., Inc.
|
547,569 | $70,362,616 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
441,303 | $55,754,221 | |
| 5 | ABBV |
AbbVie Inc.
|
134,479 | $33,840,295 | |
| 6 | AMGN |
Amgen Inc
|
37,717 | $13,658,080 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
173,350 | $9,988,427 | |
| 8 | PFE |
Pfizer Inc
|
375,974 | $9,053,453 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,988,427 | 173,350 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,427,860 | 155,447 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,716,231 | 124,513 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,579,366 | 123,711 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,721,953 | 123,611 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,874,243 | 112,711 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,328,668 | 111,893 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,913,985 | 114,302 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,297,565 | 79,402 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||